Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
-
- Overview
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
published in
has subject area
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
3,4-Dihydroxyphenylacetic Acid
-
Animals
-
Caffeine
-
Catechols
-
Corpus Striatum
-
Disease Models, Animal
-
Dopamine
-
Dose-Response Relationship, Drug
-
Immunity, Innate
-
Injections, Intraperitoneal
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Neuroprotective Agents
-
Parkinsonian Disorders
-
Purinergic P1 Receptor Antagonists
-
Purines
-
Pyrimidines
-
Receptor, Adenosine A2A
-
Receptors, Purinergic P1
-
Theobromine
-
Triazoles
-
Xanthines
Identity
Additional Document Info
start page
end page
volume
issue